Glucagon Market
Glucagon Market Size, Share & Trends Analysis Report by Product Type (Injectable and Nasal), by Application (Emergency Kits, General Use, Diagnostics & Motility, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) Forecast Period (2022-2028)
Glucagon market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period. Owing to the increasing incidence of chronic diseases such as cancer, diabetes, and others along with the rising number of out-patients concerned with diabetes is the primary factor bolstering the growth of the market across the globe. For instance, according to the World Health Organization (WHO), around 422 million out of the global population are diagnosed with diabetes. Such a rising diabetic population will further propel the growth of the market, as glucagon is a type of hormone that assists the pancreas to regulate blood glucose levels. However, a lack of awareness among consumers and stringent government regulation related to product approval are some factors restraining the market growth.
Segmental Outlook
The global glucagon market is segmented based on product type, application, and distribution channel. Based on the product type, the market is sub-segmented into injectable and nasal. Based on the application, the glucagon market is sub-segmented into emergency kits, general use, diagnostics & motility, and others. Based on the distribution channel, the market is augmented into hospital pharmacies, retail pharmacies, and online pharmacies. Among the distribution channel, hospital pharmacies are anticipated to hold a prominent market share, as glucagon is widely used as a prescribed treatment by healthcare professionals.
Among the product type, injectable glucagon is expected to hold a prominent share of the market, owing to the rising usage of end-user applications. Injectable glucagon is used to treat severe hypoglycemia and for diagnostics purposes. Thus, the growing incidence of hypoglycemia along with the lack of awareness about the disease is the major factor boosting the use of the injectable glucagon segment. In addition, the key market players are also focusing on developing new injectable glucagon to fulfill the unmet requirements. For instance, in March 2021, Zealand Pharma, a Denmark-Based pharmaceutical organization developed Zegalogue. Zealogue is an easy-to-use glucagon pen, which is sold as both an auto-injector and prefilled syringe. On the contrary, nasal glucagon is anticipated to dominate the market, due to its growing use in emergency cases.
Regional Outlooks
The global glucagon market is further segmented based on geography including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is projected to cater to a prominent share of the global glucagon market. On the other hand, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period, owing to the expiration of patents of leading drugs.
Global Glucagon Market Growth, by Region 2022-2028
North America is Anticipated to Hold a Prominent Share of the Global Glucagon Market
Among all regions, North America is projected to hold a prominent share of the global glucagon market, owing to the strong presence of key market players across the region. In countries including the US and Canada, the availability of glucagon injectables coupled with the growing geriatric population is another factor propelling the regional market growth. According to the reports published by the United Nations (UN) in 2021, the total geriatric population of the US will increase to 16.0% by 2050, from 9.3% in 2020. Owing to the combined effect of impaired pancreatic functions and rising insulin resistance with aging, the elderly population is more likely to be diagnosed with type 2 diabetes. Such factors are responsible for the higher growth of the market across the region. As glucagon is a hormone developed by the pancreas that raises blood sugar levels, however, a manmade version is used as a medicine to treat diabetes.
Market Players Outlook
The major companies serving the global glucagon market include Amgen Inc., Pfizer, Inc., Lilly USA, LLC, Xeris Biopharma Holdings, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. Key players are investing in research and development to further grow the business. For instance, in December 2021, Xeris Biopharma, Inc. along with its commercialized partner Tetris Pharma (Tetris) launched Ogluo. Ogluo is injectable glucagon in the UK. It is a prescription-based treatment used for severe hypoglycemia in adults, adolescents, and children aged 2 years and above with diabetes mellitus.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global glucagon market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Glucagon Market by Product Type
4.1.1. Injectable
4.1.2. Nasal
4.2. Global Glucagon Market by Application
4.2.1. Emergency Kits
4.2.2. General Use
4.2.3. Diagnostics and Motility
4.2.4. Others (Cardiogenic Shock)
4.3. Global Glucagon Market by Distribution Channel
4.3.1. Hospital Pharmacies
4.3.2. Retail Pharmacies
4.3.3. Online Pharmacies
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Amgen Inc.
6.2. Amphastar Pharmaceuticals
6.3. Avalon Pharma Pvt. Ltd.
6.4. Bachem Holding AG
6.5. Fresenius SE & Co. KGaA
6.6. FUJIFILM Holdings Corp.
6.7. Lilly USA, LLC
6.8. Novo Nordisk A/S
6.9. Pfizer Inc.
6.10. Svar Life Science AB
6.11. Taj Pharmaceuticals Ltd. (Taj Group)
6.12. Xeris Biopharma Holdings, Inc.
6.13. Zealand Pharma A/S
1. GLOBAL GLUCAGON MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
2. GLOBAL INJECTABLE GLUCAGON MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL NASAL GLUCAGON MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL GLUCAGON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
5. GLOBAL GLUCAGON IN EMERGENCY KITS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL GLUCAGON IN GENERAL USE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL GLUCAGON IN DIAGNOSTICS & MOTILITY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL GLUCAGON IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL GLUCAGON MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
10. GLOBAL GLUCAGON ON HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL GLUCAGON ON RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL GLUCAGON ON ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL GLUCAGON MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. NORTH AMERICAN GLUCAGON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN GLUCAGON MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
16. NORTH AMERICAN GLUCAGON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. NORTH AMERICAN GLUCAGON MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
18. EUROPEAN GLUCAGON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. EUROPEAN GLUCAGON MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
20. EUROPEAN GLUCAGON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
21. EUROPEAN GLUCAGON MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
22. ASIA-PACIFIC GLUCAGON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. ASIA-PACIFIC GLUCAGON MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC GLUCAGON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC GLUCAGON MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
26. REST OF THE WORLD GLUCAGON MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27. REST OF THE WORLD GLUCAGON MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
28. REST OF THE WORLD GLUCAGON MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
29. REST OF THE WORLD GLUCAGON MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
1. GLOBAL GLUCAGON MARKET SHARE BY PRODUCT TYPE, 2021 VS 2028 (%)
2. GLOBAL INJECTABLE GLUCAGON MARKET SHARE BY REGION, 2021 VS 2028 (%)
3. GLOBAL NASAL GLUCAGON MARKET SHARE BY REGION, 2021 VS 2028 (%)
4. GLOBAL GLUCAGON MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
5. GLOBAL GLUCAGON IN EMERGENCY KITS MARKET SHARE BY REGION, 2021 VS 2028 (%)
6. GLOBAL GLUCAGON IN GENERAL USE MARKET SHARE BY REGION, 2021 VS 2028 (%)
7. GLOBAL GLUCAGON IN DIAGNOSTICS & MOTILITY MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. GLOBAL GLUCAGON IN OTHER APPLICATIONS MARKET SHARE BY REGION, 2021 VS 2028 (%)
9. GLOBAL GLUCAGON MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
10. GLOBAL GLUCAGON ON HOSPITAL PHARMACIES MARKET SHARE BY REGION, 2021 VS 2028 (%)
11. GLOBAL GLUCAGON ON RETAIL PHARMACIES MARKET SHARE BY REGION, 2021 VS 2028 (%)
12. GLOBAL GLUCAGON ON ONLINE PHARMACIES MARKET SHARE BY REGION, 2021 VS 2028 (%)
13. GLOBAL GLUCAGON MARKET SHARE BY REGION, 2021 VS 2028 (%)
14. US GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
15. CANADA GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
16. UK GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
17. FRANCE GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
18. GERMANY GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
19. ITALY GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
20. SPAIN GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
21. REST OF EUROPE GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
22. INDIA GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
23. CHINA GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
24. JAPAN GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
25. SOUTH KOREA GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF ASIA-PACIFIC GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF THE WORLD GLUCAGON MARKET SIZE, 2021-2028 ($ MILLION)
